285 related articles for article (PubMed ID: 31365378)
41. Current perspective of progressive-fibrosing interstitial lung disease.
Kishaba T
Respir Investig; 2022 Jul; 60(4):503-509. PubMed ID: 35431170
[TBL] [Abstract][Full Text] [Related]
42. Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib.
Makino S
Mod Rheumatol; 2021 Jan; 31(1):13-19. PubMed ID: 32964766
[TBL] [Abstract][Full Text] [Related]
43. Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment.
Fragoulis GE; Nikiphorou E; Larsen J; Korsten P; Conway R
Front Med (Lausanne); 2019; 6():238. PubMed ID: 31709258
[TBL] [Abstract][Full Text] [Related]
44. Clinical Characteristics and Disease Course of Fibrosing Interstitial Lung Disease Patients in a Real-World Setting.
Kilpeläinen M; Hirvonen T; Perkonoja K; Hirsjärvi S
Medicina (Kaunas); 2023 Jan; 59(2):. PubMed ID: 36837481
[No Abstract] [Full Text] [Related]
45. Clinical features of interstitial lung diseases.
Lim GI; Lee KH; Jeong SW; Uh ST; Jin SY; Lee DH; Park JS; Choi DL; Kang CH; Park CS
Korean J Intern Med; 1996 Jun; 11(2):113-21. PubMed ID: 8854647
[TBL] [Abstract][Full Text] [Related]
46. Decision-Making Strategy for the Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD).
Yamakawa H; Ogura T; Kameda H; Kishaba T; Iwasawa T; Takemura T; Kuwano K
J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501253
[TBL] [Abstract][Full Text] [Related]
47. Rheumatoid Arthritis (RA) associated interstitial lung disease (ILD).
O'Dwyer DN; Armstrong ME; Cooke G; Dodd JD; Veale DJ; Donnelly SC
Eur J Intern Med; 2013 Oct; 24(7):597-603. PubMed ID: 23916467
[TBL] [Abstract][Full Text] [Related]
48. A cohort study of interstitial lung diseases in central Denmark.
Hyldgaard C; Hilberg O; Muller A; Bendstrup E
Respir Med; 2014 May; 108(5):793-9. PubMed ID: 24636811
[TBL] [Abstract][Full Text] [Related]
49. Pulmonary fibrosis associated with rheumatoid arthritis: from pathophysiology to treatment strategies.
Diesler R; Cottin V
Expert Rev Respir Med; 2022 May; 16(5):541-553. PubMed ID: 35695895
[TBL] [Abstract][Full Text] [Related]
50. The extended utility of antifibrotic therapy in progressive fibrosing interstitial lung disease.
Sarkar P; Avram C; Chaudhuri N
Expert Rev Respir Med; 2020 Oct; 14(10):1001-1008. PubMed ID: 32567402
[TBL] [Abstract][Full Text] [Related]
51. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
[TBL] [Abstract][Full Text] [Related]
52. The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study.
Ley B; Newton CA; Arnould I; Elicker BM; Henry TS; Vittinghoff E; Golden JA; Jones KD; Batra K; Torrealba J; Garcia CK; Wolters PJ
Lancet Respir Med; 2017 Aug; 5(8):639-647. PubMed ID: 28648751
[TBL] [Abstract][Full Text] [Related]
53. Comparison of Clinical Measures Among Interstitial Lung Disease (ILD) Patients with Usual Interstitial Pneumonia (UIP) Patterns on High-Resolution Computed Tomography.
Gibson CD; Bhatt A; Deshwal H; Li X; Goldberg JD; Ko J; Condos R
Lung; 2020 Oct; 198(5):811-819. PubMed ID: 32889595
[TBL] [Abstract][Full Text] [Related]
54. Differential diagnosis of usual interstitial pneumonia: when is it truly idiopathic?
Wuyts WA; Cavazza A; Rossi G; Bonella F; Sverzellati N; Spagnolo P
Eur Respir Rev; 2014 Sep; 23(133):308-19. PubMed ID: 25176967
[TBL] [Abstract][Full Text] [Related]
55. [Interstitial lung diseases : Classification, differential diagnosis and treatment approaches in a heterogeneous group of chronic lung disorders].
Lederer C; Buschulte K; Hellmich B; Heußel CP; Kriegsmann M; Polke M; Kreuter M
Inn Med (Heidelb); 2023 Mar; 64(3):247-259. PubMed ID: 36786822
[TBL] [Abstract][Full Text] [Related]
56. Reticulation pattern without honeycombing on high-resolution CT is associated with the risk of disease progression in interstitial lung diseases.
Mononen M; Saari E; Hasala H; Kettunen HP; Suoranta S; Nurmi H; Kärkkäinen M; Selander T; Randell J; Laurikka J; Uibu T; Koskela H; Kaarteenaho R; Purokivi M
BMC Pulm Med; 2022 Aug; 22(1):313. PubMed ID: 35965320
[TBL] [Abstract][Full Text] [Related]
57. MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression.
Juge PA; Solomon JJ; van Moorsel CHM; Garofoli R; Lee JS; Louis-Sydney F; Rojas-Serrano J; González-Pérez MI; Mejia M; Buendia-Roldán I; Falfán-Valencia R; Ambrocio-Ortiz E; Manali E; Papiris SA; Karageorgas T; Boumpas D; Antoniou KM; Sidiropoulos P; Trachalaki A; van der Vis JJ; Jamnitski A; Grutters JC; Kannengiesser C; Borie R; Kawano-Dourado L; Wemeau-Stervinou L; Flipo RM; Nunes H; Uzunhan Y; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Richez C; Schaeverbeke T; Doyle T; Wolters PJ; Debray MP; Boileau C; Porcher R; Schwartz DA; Crestani B; Dieudé P
Semin Arthritis Rheum; 2021 Oct; 51(5):996-1004. PubMed ID: 34411838
[TBL] [Abstract][Full Text] [Related]
58. Serum Progranulin Level Might Differentiate Non-IPF ILD from IPF.
Tóth NM; Müller V; Nagy T; Polivka L; Horváth P; Bohács A; Eszes N
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298130
[TBL] [Abstract][Full Text] [Related]
59. Progressive Fibrosing Interstitial Lung Diseases: Prevalence and Characterization in Two Italian Referral Centers.
Faverio P; Piluso M; De Giacomi F; Della Zoppa M; Cassandro R; Harari S; Luppi F; Pesci A
Respiration; 2020; 99(10):838-845. PubMed ID: 33264777
[TBL] [Abstract][Full Text] [Related]
60. Up-to-Date Information on Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Suda T
Clin Med Insights Circ Respir Pulm Med; 2015; 9(Suppl 1):155-62. PubMed ID: 27279757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
